Researchers ID Gastric Cancer Biomarker Aimed for Use in DTC Tests in US, China
May 06, 2011
Researchers ID Gastric Cancer Biomarker Aimed for Use in DTC Tests in US, China
Using gene expression data combined with bioinformatic analyses, scientists at the University of Georgia and China's Jilin University are developing a urine-based protein biomarker test for gastric cancer that they hope to offer as a direct-to-consumer diagnostic.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Verisante This Year to Launch Point-of-Care Biomarker-Based Skin Cancer Test
March 4, 2011 / ProteoMonitor - ASU Biodesign Scientists Hope to Apply Direct-to-Consumer Model to Proteomics Testing
February 4, 2011 / ProteoMonitor - FDA Official Offers Agency's Take on Protein IVDMIA Mock 510(k) Submissions
January 14, 2011 / ProteoMonitor - BSI Merges with MBC to Secure Access to Nanoarray Technology and New Academic and Pharma Markets
September 17, 2010 / ProteoMonitor - TGen's Center for Proteomics Named a Waters Center of Innovation
August 26, 2011 / ProteoMonitor